Advertisement

Semaglutide Linked to Reduced Risk for Alzheimer Diagnosis in T2DM

0

Semaglutide linked to significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs

ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer

0

Findings seen in people with type 2 diabetes

ASN: 1990 to 2021 Saw Global Rise in Chronic Kidney Disease Cases, Deaths in...

0

Type 2 diabetes and hypertension were the major contributors to chronic kidney disease-related deaths among women in 2021

Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes

0

Women with persistently high VMS have increased risk for diabetes versus those with persistently low VMS

Potential Genetic Link ID’d Between Thyroid Disease, Alopecia Areata

0

Significant genetic predictions of alopecia seen with hypothyroidism, Hashimoto thyroiditis, and subacute thyroiditis

AI Can Help ID Patients With Diabetes at Highest Risk for Cardiomyopathy

0

Authors say these identified patients may benefit from more aggressive heart failure preventive strategies

Small but Important Differences Seen Between Rosuvastatin, Atorvastatin

0

Rosuvastatin tied to cardiovascular and mortality benefits but also higher risk for type 2 diabetes

Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries

0

Authors say clinicians should evaluate trade-offs between pharmaceutical and surgical management of obesity

Many Seniors at Risk for Financial Precarity From Cost of Hospital Stay

0

Financial precarity more prevalent among Black and Hispanic versus White, those with less versus more than high school education

2010 to 2023 Saw Increase in GLP-1 RA, SGLT2 Inhibitor Use in Type 1...

0

Greatest increase in SGLT2 inhibitor use seen in subgroups with cardiovascular disease; greatest increase in GLP-1 RA for those with obesity